CENTEK(SZ:000931) Sou Hu Cai Jing·2025-11-24 13:30Core Viewpoint - The stock of Zhongguancun (000931) has shown a slight increase of 1.61% on November 24, 2025, closing at 5.05 yuan, with mixed capital flows indicating a net inflow from institutional and retail investors, while retail investors experienced a net outflow [1][2]. Group 1: Stock Performance - On November 24, 2025, Zhongguancun's stock closed at 5.05 yuan, reflecting a 1.61% increase with a turnover rate of 1.26% and a trading volume of 94,400 hands, amounting to a transaction value of 47.62 million yuan [1]. - The recent five-day capital flow data shows fluctuations in net inflows and outflows, with institutional investors showing a net inflow of 62.83 thousand yuan on November 24, while retail investors had a net outflow of 106.28 thousand yuan [2]. Group 2: Financial Metrics and Industry Comparison - Zhongguancun's total market capitalization is 3.803 billion yuan, with a net asset value of 1.866 billion yuan and a net profit of 49.49 million yuan, ranking 116th, 87th, and 90th respectively within the chemical pharmaceutical industry [3]. - The company reported a year-on-year decline in main operating revenue of 2.46% for the first three quarters of 2025, totaling 1.882 billion yuan, and a net profit decrease of 4.14% to 49.49 million yuan [3]. - The gross profit margin stands at 59.64%, which is higher than the industry average of 48.95%, while the net profit margin is lower at 3.25% compared to the industry average of 5.56% [3].